Location: Home
  • search
  • go
  • Relate News
  • 7/12/2025Analysing Key Trends In China's Patent-linkage System and Their Impact...
  • 7/11/2025China Issues 2nd Batch of Rare Disease Clinical Guidelines to Strength...
  • 7/11/2025China's NHSA Unveils 2025 Drug Directory Revisions and Submission Guid...
  • 7/11/2025BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
  • 7/11/2025Haleon Secures Full Ownership of Tianjin Sino‑American JV
  • 7/11/2025TandemAI and Perpetual Medicine Announce Strategic Merger
  • 7/11/2025Biocytogen Strengthens Ties with BeOne Thru Expanded Antibody Licensin...
  • 7/11/2025Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...
  • 7/11/2025Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches First Phase III T...
  • 7/11/2025Vice Premier Urges Stronger Focus on Basic Pharmaceutical Research an...
  • 7/10/2025China's Biopharma Licensing Deals Surge in H1 2025, Fueled by Cross-Bo...
  • 7/10/2025Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery...
  • 7/10/2025China Approves Three New Drugs for Cancer, ED and Pediatric Sleep Diso...
  • 7/10/2025Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...
  • 7/10/2025China's Rising Biotechnology Sector: Friend or Foe? (EGGI)
  • 7/9/2025Adagene and ConjugateBio Launch a Strategic Partnership to Advance Bis...
  • 7/9/2025NKCellTech Secures Nearly CNY100M in Series A+++ Financing
  • 7/9/2025Hansoh Pharma Launches Phase 1 Trial of HS-20093 with Adebrelimab in F...
  • 7/9/2025China Struggles to Maintain Grip on India's Bulk Drug Market Amid Risi...
  • 7/9/2025Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...
  • 7/8/2025China Approves 62 Novel Drugs in H1 2025, Led by Small Molecules and A...
  • 7/8/2025CStone Launches Global Phase I/II Trial for Trispecific Antibody CS200...
  • 7/8/2025China's Biotech Financing Hits 10-Year Low in First Half of 2025
  • 7/8/2025Sagent and Qilu Announce Partnership for Critical Injectables in U.S.
  • 7/8/2025SCG Cell's IND for SCG101V Cleared in China
  • 7/8/2025CStone and Istituto Gentili Forge Partnership for Sugemalimab in Weste...
  • 7/8/2025China Hospitals Prioritize Local Innovation, Digital Health, and Profi...
  • 7/8/2025Fosun USA and MAP International Partner to Expand Medicine Access
  • 7/8/2025Hansoh Launches Phase 1 Combo Trial of HS‑20093 ADC in ES‑SCLC
  • 7/8/2025DualityBio Launches Phase 3 Trial of HER2 ADC DB‑1303 in China for Re...
  • Page:32/808 Total number of articles:24216: [First][<<] [30] [31] [32] [33] [34] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group